Prospective Cohort Study on the Determinants of Venous THromboembolic Recurrence
Prospective Cohort Study on the Determinants of Venous THromboembolic Recurrence. BREIZH-Cohorte
University Hospital, Brest
3,400 participants
May 28, 2020
INTERVENTIONAL
Conditions
Summary
The main objective of the BREIZH-Cohorte study is to determine the incidence of recurrent short, medium and long-term thromboembolic venous disease as well as risk factors for recurrence in two specific populations: patients under 50 years of age, men and women (5 year recurrence), as well as cancer patients (all ages) (1 year recurrence).
Eligibility
Inclusion Criteria4
- Subject aged 18 or over, or a minor with the consent of the parents and the minor, presenting with a thromboembolic venous disease
- and under or any age if active cancer
- Affiliated to social security
- Accepting to participate in the study.
Exclusion Criteria2
- Inability to communicate (comprehension disorder).
- Refusal to participate.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Biological samples will be taken from the subjects included
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04297085